1.
Cardiovascular disease risk scores in identifying future frailty: the Whitehall II prospective cohort study
by Bouillon, Kim
Heart (British Cardiac Society), 2013-05, Vol.99 (10), p.737-742
2.
Decline in low-density lipoprotein cholesterol concentration: lipid-lowering drugs, diet, or physical activity? Evidence from the Whitehall II study
by Bouillon, Kim
Heart (British Cardiac Society), 2011-06, Vol.97 (11), p.923-930
3.
Factors correlated with disclosure of HIV infection in the French Antilles and French Guiana: results from the ANRS-EN13-VESPA-DFA Study
by Bouillon, Kim
AIDS (London), 2007-01, Vol.21 Suppl 1 (Suppl 1), p.S89-S94
4.
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study
by Witkowski, Benoit, PhD
The Lancet infectious diseases, 2016, Vol.17 (2), p.174-183
5.
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study
by Witkowski, Benoit
The Lancet infectious diseases, 2017-02, Vol.17 (2), p.174-183
6.
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study
by Witkowski, Benoit
The Lancet infectious diseases, 2016-11-03, Vol.17 (2), p.174-183
7.
Changes in biochemical markers of osteoblastic activity during the menstrual cycle
by KASPERSEN NIELSEN, H
The journal of clinical endocrinology and metabolism, 1990, Vol.70 (5), p.1431-1437
